According to veterinary medical experts, upper respiratory infections– also called canine infectious respiratory disease (CIRD) is mainly caused in spaces occupied or visited by many pets such as boarding houses, groomers, and parks.
This report contains market size and forecasts of Small Animals Respiratory Diseases Treatment in Global, including the following market information:
Global Small Animals Respiratory Diseases Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Small Animals Respiratory Diseases Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anthelmintics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Small Animals Respiratory Diseases Treatment include Zoetis, Inc., Merck Animal Health, Boehringer Ingelheim GmbH, Bayer AG, Ceva Animal Health, Vetoquinol SA and Virbac Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Small Animals Respiratory Diseases Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Small Animals Respiratory Diseases Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Small Animals Respiratory Diseases Treatment Market Segment Percentages, by Type, 2021 (%)
Anthelmintics
Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroids
Antibiotics
Antihistamines
Phosphodiesterase (PDE) inhibitors
Bronchodilators
Antineoplastic Agents
Global Small Animals Respiratory Diseases Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Small Animals Respiratory Diseases Treatment Market Segment Percentages, by Application, 2021 (%)
Allergic Pneumonitis
Canine Influenza
Canine Nasal Mites
Lung Nematodes
Neoplasia Of Respiratory System
Pneumonia
Rhinitis And Sinusitis
Tonsilitis
Global Small Animals Respiratory Diseases Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Small Animals Respiratory Diseases Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Animals Respiratory Diseases Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Small Animals Respiratory Diseases Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zoetis, Inc.
Merck Animal Health
Boehringer Ingelheim GmbH
Bayer AG
Ceva Animal Health
Vetoquinol SA
Virbac Ltd.